NO328483B1 - Polypeptidforbindelser, farmasoytiske preparater inneholdende disse og fremgangsmate for a fremstille forbindelsene samt deres anvendelse. - Google Patents

Polypeptidforbindelser, farmasoytiske preparater inneholdende disse og fremgangsmate for a fremstille forbindelsene samt deres anvendelse. Download PDF

Info

Publication number
NO328483B1
NO328483B1 NO19971544A NO971544A NO328483B1 NO 328483 B1 NO328483 B1 NO 328483B1 NO 19971544 A NO19971544 A NO 19971544A NO 971544 A NO971544 A NO 971544A NO 328483 B1 NO328483 B1 NO 328483B1
Authority
NO
Norway
Prior art keywords
phenyl
alkoxy
group
substituted
nmr
Prior art date
Application number
NO19971544A
Other languages
English (en)
Norwegian (no)
Other versions
NO971544L (no
NO971544D0 (no
Inventor
Akira Yamada
Hidenori Ohki
Masaki Tomishima
Hisashi Takasugi
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26305774&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO328483(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB9420425A external-priority patent/GB9420425D0/en
Priority claimed from GBGB9508745.8A external-priority patent/GB9508745D0/en
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of NO971544D0 publication Critical patent/NO971544D0/no
Publication of NO971544L publication Critical patent/NO971544L/no
Publication of NO328483B1 publication Critical patent/NO328483B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO19971544A 1994-10-07 1997-04-04 Polypeptidforbindelser, farmasoytiske preparater inneholdende disse og fremgangsmate for a fremstille forbindelsene samt deres anvendelse. NO328483B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9420425A GB9420425D0 (en) 1994-10-07 1994-10-07 New compound
GBGB9508745.8A GB9508745D0 (en) 1995-04-28 1995-04-28 New compound
PCT/JP1995/001983 WO1996011210A1 (en) 1994-10-07 1995-09-29 Cyclic hexapeptides having antibiotic activity

Publications (3)

Publication Number Publication Date
NO971544D0 NO971544D0 (no) 1997-04-04
NO971544L NO971544L (no) 1997-06-04
NO328483B1 true NO328483B1 (no) 2010-03-01

Family

ID=26305774

Family Applications (2)

Application Number Title Priority Date Filing Date
NO19971544A NO328483B1 (no) 1994-10-07 1997-04-04 Polypeptidforbindelser, farmasoytiske preparater inneholdende disse og fremgangsmate for a fremstille forbindelsene samt deres anvendelse.
NO2010016C NO2010016I2 (no) 1994-10-07 2010-08-09 Micafungin Sodium

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO2010016C NO2010016I2 (no) 1994-10-07 2010-08-09 Micafungin Sodium

Country Status (27)

Country Link
US (2) US6107458A (de)
EP (1) EP0788511B1 (de)
JP (2) JP2897427B2 (de)
KR (1) KR100353303B1 (de)
CN (1) CN1203089C (de)
AR (1) AR041770A1 (de)
AT (1) ATE229541T1 (de)
AU (1) AU696949B2 (de)
BR (2) BR9504791B1 (de)
CA (1) CA2202058C (de)
DE (2) DE122008000025I2 (de)
DK (1) DK0788511T3 (de)
ES (1) ES2187575T3 (de)
FI (1) FI119988B (de)
FR (1) FR08C0028I2 (de)
HK (1) HK1004136A1 (de)
HU (1) HU228151B1 (de)
IL (1) IL115484A (de)
LU (1) LU91452I2 (de)
MX (1) MX9702531A (de)
NL (1) NL300352I2 (de)
NO (2) NO328483B1 (de)
OA (1) OA10475A (de)
PT (1) PT788511E (de)
RU (1) RU2165423C2 (de)
TR (1) TR199501229A2 (de)
WO (1) WO1996011210A1 (de)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5696084A (en) * 1996-08-16 1997-12-09 Abbott Laboratories Amino-lipopetide antifungal agents
AUPO371596A0 (en) * 1996-11-19 1996-12-12 Fujisawa Pharmaceutical Co., Ltd. New compound
AUPO381496A0 (en) * 1996-11-25 1996-12-19 Fujisawa Pharmaceutical Co., Ltd. New compound
US6291680B1 (en) * 1997-06-18 2001-09-18 Fujisawa Pharmaceutical Co., Ltd. Production process
AU756792B2 (en) * 1998-02-09 2003-01-23 Fujisawa Pharmaceutical Co., Ltd. New compound
HUP0102515A3 (en) * 1998-02-09 2001-12-28 Fujisawa Pharmaceutical Co Cyclopeptides, process for their preparation, pharmaceutical compositions comprising thereof and their use
US7084279B1 (en) * 1999-02-11 2006-08-01 Emisphere Technologies Inc. Oxadiazole compounds and compositions for delivering active agents
AU3492100A (en) * 1999-02-11 2000-08-29 Emisphere Technologies, Inc. Oxadiazole compounds and compositions for delivering active agents
AUPP999799A0 (en) * 1999-04-27 1999-05-20 Fujisawa Pharmaceutical Co., Ltd. New compound
AUPQ066399A0 (en) 1999-05-31 1999-06-24 Fujisawa Pharmaceutical Co., Ltd. Antifungal combination use
TWI233805B (en) * 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent
CA2380176A1 (en) 1999-07-27 2001-02-01 Aventis Pharma Deutschland Gmbh Novel cyclohexapeptide compounds, processes for their production and their use as a pharmaceutical
AUPQ462399A0 (en) * 1999-12-13 2000-01-13 Fujisawa Pharmaceutical Co., Ltd. New use
TWI250992B (en) * 2000-02-21 2006-03-11 Astellas Pharma Inc Polypeptide compounds for the prophylactic and/or therapeutic treatment of infectious diseases caused by pathogenic microorganisms
ES2191516B1 (es) * 2000-07-28 2005-01-01 Consejo Superior De Investigaciones Cientificas Antibioticos antifungicos de naturaleza peptidica inhibidores de la germinacion y el crecimiento de hongos fitopatogenos.
AUPQ938700A0 (en) * 2000-08-14 2000-09-07 Fujisawa Pharmaceutical Co., Ltd. Antifungal combination use
US7867516B2 (en) 2001-01-29 2011-01-11 Shionogi & Co., Ltd. Medicinal preparation containing 5-methyl-1-phenyl-2-(1h)-pyridone as active ingredient
JP2005053782A (ja) * 2001-08-31 2005-03-03 Fujisawa Pharmaceut Co Ltd 環状リポペプチド化合物の新規結晶
IL163666A0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents
WO2004014879A1 (en) * 2002-08-08 2004-02-19 Fujisawa Pharmaceutical Co., Ltd. New process
AU2003903205A0 (en) * 2003-06-23 2003-07-10 Fujisawa Pharmaceutical Co., Ltd. New compound
ES2298821T3 (es) 2003-07-22 2008-05-16 Theravance, Inc. Utilizacion de un agente antifungico de equinocandina en combinacion con un agente antibacteriano glicopeptidico.
CN1845751A (zh) * 2003-09-05 2006-10-11 默克公司 固定相和利用该固定相的纯化方法
AU2004274309B2 (en) * 2003-09-22 2010-04-08 Msd K.K. Novel piperidine derivative
US7476673B2 (en) * 2003-12-30 2009-01-13 Allergan, Inc. Disubstituted chalcone oximes as selective agonists of RARγ retinoid receptors
AU2005245470A1 (en) * 2004-05-20 2005-12-01 Foldrx Pharmaceuticals, Inc. 2-((hetero) aryl)-benzoxazole compounds and derivatives, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
TW200624427A (en) 2004-09-20 2006-07-16 Xenon Pharmaceuticals Inc Heterocyclic derivatives and their use as therapeutic agents
BRPI0515488A (pt) 2004-09-20 2008-07-29 Xenon Pharmaceuticals Inc derivados de heterocìclicos e seu uso como agentes terapêuticos
WO2006034338A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as mediators of stearoyl-coa desaturase
WO2006034315A2 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
US7829712B2 (en) 2004-09-20 2010-11-09 Xenon Pharmaceuticals Inc. Pyridazine derivatives for inhibiting human stearoyl-CoA-desaturase
CN101083994A (zh) 2004-09-20 2007-12-05 泽农医药公司 杂环衍生物及其用作硬脂酰CoA去饱和酶抑制剂的用途
BRPI0515482A (pt) 2004-09-20 2008-07-22 Xenon Pharmaceuticals Inc derivados heterocìclicos e seus usos como agentes terapêuticos
WO2006044682A1 (en) * 2004-10-13 2006-04-27 Ptc Therapeutics, Inc. Compounds for nonsense suppression, and methods for their use
BRPI0611187A2 (pt) 2005-06-03 2010-08-24 Xenon Pharmaceuticals Inc derivados aminotiazàis como inibidores da estearoil-coa desaturase humana
US7947707B2 (en) * 2005-10-07 2011-05-24 Kissei Pharmaceutical Co., Ltd. Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
CN101516387B (zh) * 2006-07-26 2014-06-04 桑多斯股份公司 卡泊芬净制剂
US8853392B2 (en) 2007-06-03 2014-10-07 Vanderbilt University Benzamide mGluR5 positive allosteric modulators and methods of making and using same
TWI479995B (zh) 2007-08-13 2015-04-11 孟山都科技有限責任公司 控制植物寄生性線蟲的方法及以其處理過之種子
RU2470939C2 (ru) * 2007-10-29 2012-12-27 Астеллас Фарма Инк. Полипептидное соединение
US8034806B2 (en) 2007-11-02 2011-10-11 Vanderbilt University Bicyclic mGluR5 positive allosteric modulators and methods of making and using same
MX2010014569A (es) * 2008-06-24 2011-03-29 Irm Llc Compuestos y metodos para modular los receptores acoplados con proteina-g.
US9394340B2 (en) 2009-03-24 2016-07-19 Cadila Healthcare Limited Purification process for lipopeptides
BR112013023531A2 (pt) 2011-04-04 2016-12-06 Xellia Pharmaceuticals Aps processo de um único vaso para a fabricação de micafungina ou de um sal desta
AU2012244435B2 (en) 2011-04-20 2017-06-15 Xellia Pharmaceuticals Aps Method for purification of Micafungin
CN102775476B (zh) 2011-05-12 2015-01-07 上海天伟生物制药有限公司 一种米卡芬净钠盐的制备方法
EP2709609B1 (de) 2011-05-17 2017-10-04 Shionogi & Co., Ltd. Heterozyklische verbindungen
RU2014113624A (ru) * 2011-09-09 2015-10-20 Сандоз Аг Получение промежуточных продуктов для получения микафунгина
CN102627689B (zh) * 2012-03-30 2014-08-06 上海天伟生物制药有限公司 一种环肽类化合物的水合物及其制备方法和用途
CN102659930B (zh) * 2012-03-30 2014-04-23 上海天伟生物制药有限公司 一种高纯度环肽类物质的晶体及其制备方法和用途
CN102627688B (zh) 2012-03-30 2014-12-31 上海天伟生物制药有限公司 一种高纯度环肽化合物及其制备方法和用途
CN104861044B (zh) * 2014-05-29 2019-03-01 上海天伟生物制药有限公司 一种环肽类化合物的溶剂合物及其制备方法和用途
WO2016056023A2 (en) * 2014-10-07 2016-04-14 Alaparthi Lakshmi Prasad Intermediates and processes to prepare micafungin
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
EP3485873A1 (de) 2017-11-17 2019-05-22 Cadila Healthcare Limited Stabile pharmazeutische injizierbare zusammensetzungen von micafungin
CN108752430B (zh) * 2018-05-31 2022-02-18 杭州中美华东制药有限公司 米卡芬净钠新晶型及其制备方法
WO2020013116A1 (ja) * 2018-07-10 2020-01-16 京都薬品工業株式会社 Ptp-1b阻害剤およびその用途
CN110734408A (zh) * 2019-10-22 2020-01-31 重庆康乐制药有限公司 一种米卡芬净类衍生物侧链中间体的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE990233A1 (en) * 1990-06-18 2000-11-15 Fujisawa Pharmaceutical Co New Polypeptide Compound and a Process for Preparation thereof
CA2091663C (en) * 1992-03-19 2007-10-30 Frederick Joseph Burkhardt Cyclic peptide antifungal agents and process for preparation thereof

Also Published As

Publication number Publication date
JP2897427B2 (ja) 1999-05-31
KR970707150A (ko) 1997-12-01
IL115484A (en) 2000-07-16
OA10475A (en) 2002-04-08
CA2202058C (en) 2007-11-06
DE69529172T2 (de) 2003-04-17
BR9504791B1 (pt) 2010-10-05
NO2010016I1 (no) 2010-08-16
LU91452I2 (fr) 2008-08-04
TR199501229A2 (tr) 1996-07-21
HUT77736A (hu) 1998-07-28
DE122008000025I2 (de) 2011-02-17
FI119988B (fi) 2009-05-29
BRPI9504791B8 (pt) 2019-12-31
JPH10507174A (ja) 1998-07-14
NO971544L (no) 1997-06-04
RU2165423C2 (ru) 2001-04-20
DK0788511T3 (da) 2003-03-31
US6107458A (en) 2000-08-22
AR041770A1 (es) 2005-06-01
NO2010016I2 (no) 2011-10-17
NL300352I2 (nl) 2008-11-03
NO971544D0 (no) 1997-04-04
AU696949B2 (en) 1998-09-24
ATE229541T1 (de) 2002-12-15
CN1168675A (zh) 1997-12-24
CN1203089C (zh) 2005-05-25
US6265536B1 (en) 2001-07-24
FI971397A (fi) 1997-05-27
WO1996011210A1 (en) 1996-04-18
NL300352I1 (nl) 2008-08-01
PT788511E (pt) 2003-04-30
DE69529172D1 (de) 2003-01-23
EP0788511A1 (de) 1997-08-13
HK1004136A1 (en) 1998-11-20
FR08C0028I2 (de) 2009-11-20
HU228151B1 (en) 2012-12-28
KR100353303B1 (ko) 2003-01-15
BR9504791A (pt) 1996-10-22
CA2202058A1 (en) 1996-04-18
JPH10324695A (ja) 1998-12-08
MX9702531A (es) 1997-06-28
FI971397A0 (fi) 1997-04-04
FR08C0028I1 (de) 2008-08-15
AU3578095A (en) 1996-05-02
ES2187575T3 (es) 2003-06-16
EP0788511B1 (de) 2002-12-11
DE122008000025I1 (de) 2008-08-21
JP3518665B2 (ja) 2004-04-12
IL115484A0 (en) 1996-01-19

Similar Documents

Publication Publication Date Title
NO328483B1 (no) Polypeptidforbindelser, farmasoytiske preparater inneholdende disse og fremgangsmate for a fremstille forbindelsene samt deres anvendelse.
CA2730793C (en) Azole compound
EA004673B1 (ru) Непептидильные ингибиторы vla-4-зависимого связывания клеток, применяемые при лечении воспалительных, аутоимунных и респираторных заболеваний
US6232290B1 (en) Cyclic hexapeptides with antimicrobial activity
AU674512B2 (en) Peptides having tachykinin antagonist activity
WO2007001335A2 (en) Ramoplanin derivatives possessing antibacterial activity
TW438773B (en) Indole derivatives
TW425392B (en) Oxazolidinonecarboxylic acid derivatives for use as adhesion receptor antagonists preparation process therefor and pharmaceutical composition comprising the same
WO2012115118A1 (ja) ポリペプチド化合物
JP3906690B2 (ja) 環状ヘキサペプチド誘導体
JPH0570495A (ja) 環式ヘキサペプチド化合物
JP2001505880A (ja) 抗微生物活性を有する環状ヘキサペプチド
UA58529C2 (uk) Карбоксизаміщені циклічні похідні карбоксаміду, спосіб їх одержання, фармацевтична композиція на їх основі та спосіб лікування кашлю, астми та бронхіту
WO1995000536A1 (en) Peptide compounds
US5654400A (en) Process for making peptide compounds having tachykinin antagonistic activity
JP2005524640A (ja) 新規化合物
JP2006070014A (ja) 2−アミノベンゾチアゾール誘導体

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: PLOUGMANN 6 VINGTOFT POSTBOKS 1003 SENTRUM OSLO, 0

SPCF Filing of supplementary protection certificate

Free format text: PRODUCT NAME: MICAFUNGIN SODIUM; NAT. REG. NO/DATE: EU/1/08/448/001-002 20080521; FIRST REG. NO/DATE: 1/08/448/001-002 20080425

Spc suppl protection certif: 2010016

Filing date: 20100809

SPCG Granted supplementary protection certificate

Free format text: PRODUCT NAME: MICAFUNGIN SODIUM; NAT. REG. NO/DATE: EU/1/08/448/001-002 20080521; FIRST REG. NO/DATE: 1/08/448/001-002 20080425

Spc suppl protection certif: 2010016

Filing date: 20100809

Extension date: 20200929

MK1K Patent expired
SPCX Expiry of an spc

Spc suppl protection certif: 2010016

Effective date: 20201001